Form 4 for TECH Bio-Techne
Accepted 2024-09-03 00:00:00 ET · period of report 2024-08-29 · accession 0001062993-24-015997 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-03 | 2024-08-29 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $66.97 | +1,492 | 41.4K | +4% | +$99.9K |
| D | 2024-09-03 | 2024-08-29 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -1,492 | 115.7K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-29 | M | A | 1,492 | $66.97 | 41,434 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-08-29 | M | D | 1,492 | $0.00 | 115,724 | D | $66.97 · — to 2027-08-05 | 1,492 Common Stock | (F1) Fully exercisable. |